Publikationen 2019

1. Heinzl M, Resl M, Klammer C, Egger M, Dieplinger B, Clodi M. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is not induced in artificial human inflammation and is not correlated with inflammatory response. Infect Immun 2019 (in press).

2. Obendorf F, Klammer C, Heinzl M, Egger-Salmhofer M, Resl M, Dieplinger B, Clodi M. Intra-hospital mortality of influenza patients during the 2017/2018 influenza season – report of a tertiary care hospital in Austria. Wien Med Wochenschr 2019 (in press). [PubMed]

3. Francic V, Keppel M, Schwetz V, Trummer C, Pandis M, Borzan V, Grübler MR, Verheyen ND, Kleber ME, Delgado G, Moissl AP, Dieplinger B, März W, Tomaschitz A, Pilz S, Obermayer-Pietsch B. Are soluble ST2 levels influenced by vitamin D and/or the seasons? Endocr Connect 2019;8:691–700. [PubMed]

4. Scharnagl H, Stojakovic T, Dieplinger B, Dieplinger H, Erhart G, Kostner GM, Hermann M, März W, Grammer TB. Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays. Atherosclerosis 2019;289:206-13. [PubMed

5. Pusceddul I, Dieplinger B, Mueller T. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans. Clin Chim Acta 2019;495:493-500. [PubMed

6. Egger M, Maier E, Robier C. Light chain myeloma with bar-shaped intranuclear kappa light chain inclusions. Ann Hematol 2019;98:2237-8. [PubMed

7. Dieplinger B, Egger M, Haltmayer M, Mueller T, Luft C, Hinterreiter F, Pernerstorfer T. Reply: Activated clotting time monitoring in vascular surgery: so bad, no bad. J Vasc Surg 2019;69:1651-2. [PubMed